Renal Outcomes in PARAGLIDE-HF and PARAGON-HF

25 August 2023 (08:45 - 09:00)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Muthiah Vaduganathan

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail

EMPEROR - Empagliflozin in Patients with Chronic Heart Failure

Professor M. Packer (Dallas, US)

Presentation thumbnail

Effects of Dapagliflozin in Patients with Heart Failure and Deterioration of Kidney Function Below eGFR 25ml/min/1.73m^2

Professor S. Solomon (Boston, US)

Presentation thumbnail

STRONG-HF

Professor P. Ponikowski (Wroclaw, PL)

Presentation thumbnail

OPT-PACE - Optimising therapy in patients with pacemakers

Doctor K. Witte (Leeds, GB)

Presentation thumbnail

The ADVOR trial: update on renal interactions

Doctor J. Dauw (Aalst, BE)

Access the full session

Session thumbnail

Clinical trial updates on heart failure

The Event

Event poster

ESC Congress 2023

25 August 2023 08:45 CET

You may be interested in

Congress Presentation

Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF

11 May 2024

Congress Presentation

Difficulties of heart failure management in chronic kidney disease.

23 May 2022

Congress Presentation

Cardiovascular and renal outcomes related to urinary albumin to creatinine ratio in patients with heart failure and reduced ejection fraction: A pooled analysis of ATMOSPHERE and PARADIGM-HF

11 May 2024

Congress Presentation

Kidney parameters of the EMPAGHF cohort.

28 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources